Navigating the Complexities of Recognizing, Diagnosing and Treating Transthyretin Amyloid Polyneuropathy (ATTR-PN)
October 31, 2023
In this program, ATTR-PN experts (Chair Dr. Sami Khella, and faculty members Dr. Morie Gertz and Dr. Amanda Peltier) will describe the signs, symptoms, hereditability, and other factors that indicate possible ATTR-PN. The diagnostic process will be explained, and data with currently available and emerging therapies will be discussed.
CME 1.00 Credits In-Progress
DOACs and Intracranial Hemorrhage: Best Practices to Optimize Outcomes
October 15, 2023
In this program, Program Chair Dr. Joshua Goldstein and an expert multidisciplinary faculty (Dr. Casey May, Dr. Anne Alexandrov, and Dr. Ashkan Shoamanesh) will provide attendees with best practices for optimal management of intracranial hemorrhage.
1.00 Credits In-Progress
Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes
March 12, 2023
This program will focus on why clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants.
No Credit Available
Multidisciplinary Strategies for Managing Patients with Worsening Heart Failure with Reduced Ejection Fraction
September 18, 2022
This program will provide a review of the benefits of the multidisciplinary team to identifying and treating WHF, including the strategies and benefits of ambulatory intravenous diuretic administration and review of the roles for new and emerging therapies for recent WHF.
No Credit Available
The Integral Role of Nephrology Nurses in the Management of Hyperkalemia
September 18, 2022
In this program, experts in the management of hyperkalemia will 1) identify goals and strategies in managing acute and chronic hyperkalemia, 2) emphasize the importance of maintaining CKD patients on RAASi to improve clinical outcomes, 3) interpret the evidence with new potassium binders in the treatment of patients with hyperkalemia with CKD and also with ESRD undergoing hemodialysis, and 4) explain how to best use these new therapies in clinical practice
No Credit Available
Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
March 23, 2022
In this program, HF experts will provide insights into mechanisms and clinical evidence for improving myocardial contractility, and emphasize the need for a more personalized treatment of HFrEF to optimize patient outcomes.
No Credit Available
SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice
March 19, 2022
Information on best uses of SGLT2 inhibitors for patients with HF will be disseminated through lecture, interactive case presentation, panel discussion, and question-and-answer with experts.
No Credit Available
Keys to Prevention and Risk Reduction with Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
March 13, 2022
In this program, Chair Dr. S. Claiborne Johnston, Dr. Brett Cucchiara, Dr. Louise McCullough, and Dr. Carlos Molina will interpret the evidence for DAPT, provide insights into the choice of clopidogrel or ticagrelor to add to ASA, describe deficiencies in care preventing optimal use of DAPT, and explain remedies.
No Credit Available
Managing the Heart Failure Patient with Reduced Ejection Fraction: New Perspectives and Emerging Evidence
November 13, 2021
In this program, HF experts will provide insights into mechanisms for improving myocardial contractility and clinical evidence and emphasize the need for a more personalized treatment of HFrEF.
No Credit Available
Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
November 04, 2021
This program will address challenges for interventional cardiologists in using antiplatelet therapy, with the overarching focus on balancing the need to reduce ischemic risk and lower bleeding risk.
No Credit Available
2021 MASE Chapter Meeting
October 17, 2021
In this educational initiative, an expert in the management of Cushing’s disease will describe best practices for diagnosis and treatment to improve long-term outcomes for patients.
No Credit Available
Insights into Using Dual Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
October 16, 2021
In this program, experts in the management of stroke with antiplatelet therapy will interpret clinical trial evidence and identify patients for use of DAPT.
No Credit Available